{"id":"https://openalex.org/W1990622503","doi":"https://doi.org/10.1097/coc.0b013e3181d2734a","title":"Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma","display_name":"Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma","publication_year":2010,"publication_date":"2010-05-11","ids":{"openalex":"https://openalex.org/W1990622503","doi":"https://doi.org/10.1097/coc.0b013e3181d2734a","mag":"1990622503","pmid":"https://pubmed.ncbi.nlm.nih.gov/20458210","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3030655"},"language":"en","primary_location":{"id":"doi:10.1097/coc.0b013e3181d2734a","doi":"https://doi.org/10.1097/coc.0b013e3181d2734a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e3181d2734a","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3030655","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087332592","display_name":"Igor A. Astsaturov","orcid":"https://orcid.org/0000-0002-8613-1890","observed_orcids":["https://orcid.org/0000-0002-8613-1890"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Igor A. Astsaturov","raw_affiliation_strings":["Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111\u20132497, USA","Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111\u20132497, USA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053128814","display_name":"Neal J. Meropol","orcid":"https://orcid.org/0000-0001-6353-7364","observed_orcids":["https://orcid.org/0000-0001-6353-7364"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal J. Meropol","raw_affiliation_strings":["Lombardi Cancer Center, Washington, DC","University Hospitals Case Medical Center and Case Western Reserve University, Cleveland OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]},{"raw_affiliation_string":"University Hospitals Case Medical Center and Case Western Reserve University, Cleveland OH","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049901305","display_name":"R. Katherine Alpaugh","orcid":"https://orcid.org/0000-0002-6775-5323","observed_orcids":["https://orcid.org/0000-0002-6775-5323"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Katherine Alpaugh","raw_affiliation_strings":["Protocol Support Lab, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protocol Support Lab, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barbara A. Burtness","raw_affiliation_strings":["Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112748795","display_name":"Jonathan D. Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan D. Cheng","raw_affiliation_strings":["Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sue McLaughlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sue McLaughlin","raw_affiliation_strings":["Protocol Management Office, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protocol Management Office, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090472587","display_name":"Andr\u00e9 Rogatko","orcid":"https://orcid.org/0000-0001-8935-8890","observed_orcids":["https://orcid.org/0000-0001-8935-8890"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Rogatko","raw_affiliation_strings":["Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021223600","display_name":"Zhiheng Xu","orcid":"https://orcid.org/0000-0002-4809-2851","observed_orcids":["https://orcid.org/0000-0002-4809-2851","https://orcid.org/0009-0008-0751-5548"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhiheng Xu","raw_affiliation_strings":["Department of Biostatistics, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018244695","display_name":"James C. Watson","orcid":"https://orcid.org/0000-0002-1164-8588","observed_orcids":["https://orcid.org/0000-0002-1164-8588"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James C. Watson","raw_affiliation_strings":["Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis M. Weiner","raw_affiliation_strings":["Lombardi Cancer Center, Washington, DC","University Hospitals Case Medical Center and Case Western Reserve University, Cleveland OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lombardi Cancer Center, Washington, DC","institution_ids":["https://openalex.org/I4390039356"]},{"raw_affiliation_string":"University Hospitals Case Medical Center and Case Western Reserve University, Cleveland OH","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103737583","display_name":"Steven J. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven J. Cohen","raw_affiliation_strings":["Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5018244695","https://openalex.org/A5023000705","https://openalex.org/A5087332592","https://openalex.org/A5103737583","https://openalex.org/A5112748795"],"corresponding_institution_ids":["https://openalex.org/I1289437631"],"apc_list":null,"apc_paid":null,"fwci":1.7367,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.83784616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"34","issue":"1","first_page":"70","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-pancreatic-adenocarcinoma","display_name":"metastatic pancreatic adenocarcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gemcitabine-refractory-pancreatic-cancer","display_name":"gemcitabine-refractory pancreatic cancer","score":0.9150000214576721},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor-inhibition","display_name":"vascular endothelial growth factor inhibition","score":0.8159999847412109},{"id":"https://openalex.org/keywords/coagulation-markers","display_name":"coagulation markers","score":0.8270000219345093},{"id":"https://openalex.org/keywords/d-dimer","display_name":"D-dimer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/thrombin-antithrombin-complex","display_name":"thrombin-antithrombin complex","score":0.9259999990463257},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8040000200271606},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6990000009536743},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9440779685974121},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.886773407459259},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.814597487449646},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.789323091506958},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6762832403182983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6551214456558228},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5728049278259277},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4946260154247284},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3422526717185974},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.320078045129776},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31451690196990967}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010534","descriptor_name":"Peritoneal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010534","descriptor_name":"Peritoneal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010534","descriptor_name":"Peritoneal Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/coc.0b013e3181d2734a","doi":"https://doi.org/10.1097/coc.0b013e3181d2734a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e3181d2734a","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:20458210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20458210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:3030655","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3030655","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Clin Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3030655","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3030655","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Clin Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8399999737739563}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3628222385","display_name":null,"funder_award_id":"P30CA006927","funder_id":"https://openalex.org/F4320332523","funder_display_name":"Fox Chase Cancer Center"},{"id":"https://openalex.org/G9000202480","display_name":null,"funder_award_id":"CA006927","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000285491","display_name":"Comprehensive Cancer Center Program at Fox Chase","funder_award_id":"P30CA006927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332523","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W82876830","https://openalex.org/W152343487","https://openalex.org/W1539571840","https://openalex.org/W1931508686","https://openalex.org/W1964589941","https://openalex.org/W1971811939","https://openalex.org/W1974906718","https://openalex.org/W1975440632","https://openalex.org/W1989664813","https://openalex.org/W1990161374","https://openalex.org/W1991792727","https://openalex.org/W1994861753","https://openalex.org/W2000292756","https://openalex.org/W2009337734","https://openalex.org/W2013564192","https://openalex.org/W2021020268","https://openalex.org/W2026663786","https://openalex.org/W2042098847","https://openalex.org/W2052492883","https://openalex.org/W2058405988","https://openalex.org/W2067141748","https://openalex.org/W2082243630","https://openalex.org/W2085355966","https://openalex.org/W2087884039","https://openalex.org/W2094068309","https://openalex.org/W2096134439","https://openalex.org/W2098282622","https://openalex.org/W2099274861","https://openalex.org/W2100945863","https://openalex.org/W2109134893","https://openalex.org/W2124863710","https://openalex.org/W2125447919","https://openalex.org/W2126275851","https://openalex.org/W2130637301","https://openalex.org/W2136438977","https://openalex.org/W2139248078","https://openalex.org/W2145835533","https://openalex.org/W2157769714","https://openalex.org/W2158134441","https://openalex.org/W2230554281","https://openalex.org/W2339361819"],"related_works":["https://openalex.org/W2249641340","https://openalex.org/W2084555154","https://openalex.org/W2094037194","https://openalex.org/W2124863710","https://openalex.org/W1975193398","https://openalex.org/W2026107878","https://openalex.org/W2206443486","https://openalex.org/W2766553372","https://openalex.org/W2093930824","https://openalex.org/W4238710595"],"abstract_inverted_index":{"PURPOSE:":[0],"Treatment":[1],"options":[2],"are":[3,223],"limited":[4],"for":[5,46,159],"advanced":[6],"pancreatic":[7,23,50,213],"cancer":[8],"progressive":[9,62],"after":[10],"gemcitabine":[11],"therapy.":[12],"The":[13,149],"vascular":[14],"endothelial":[15,38],"growth":[16,39],"factor":[17,40],"pathway":[18],"is":[19],"biologically":[20],"important":[21],"in":[22,76,102,133,142,173,182,210],"cancer,":[24],"and":[25,91,117,136,164,170,176,179,188,196,216,219,228],"docetaxel":[26,96,204],"has":[27],"modest":[28],"antitumor":[29,208],"activity.":[30],"We":[31],"evaluated":[32],"the":[33,36,58,106,130,139,155],"role":[34],"of":[35,57,129,138],"anti-vascular":[37],"antibody":[41],"bevacizumab":[42,72,75,87,94],"as":[43],"second-line":[44],"treatment":[45],"patients":[47,82,132,141],"with":[48,54,78,105,193,201,225],"metastatic":[49,55,212],"cancer.":[51,214],"DESIGN:":[52],"Patients":[53],"adenocarcinoma":[56],"pancreas":[59],"who":[60],"had":[61],"disease":[63],"on":[64],"a":[65],"gemcitabine-containing":[66],"regimen":[67],"were":[68,83,100,123,145,167,191],"randomized":[69],"to":[70,86,93,154],"receive":[71],"alone":[73,88],"or":[74,202],"combination":[77],"docetaxel.":[79],"RESULTS:":[80],"Thirty-two":[81],"enrolled;":[84],"16":[85,92,131,140],"(Arm":[89,97],"A)":[90],"plus":[95],"B).":[98],"Toxicities":[99],"greater":[101],"Arm":[103,134,143,174,183],"B":[104,144],"most":[107],"common":[108],"grade":[109],"3/4":[110],"nonhematologic":[111],"toxicities":[112],"including":[113],"fatigue,":[114],"diarrhea,":[115],"dehydration,":[116],"anorexia.":[118],"No":[119],"confirmed":[120],"objective":[121],"responses":[122],"observed.":[124],"At":[125],"4":[126],"months,":[127],"2":[128],"A":[135,175],"3":[137],"free":[146],"from":[147],"progression.":[148],"study":[150],"was":[151],"stopped":[152],"according":[153],"early":[156],"stopping":[157],"rule":[158],"futility.":[160],"Median":[161],"progression-free":[162],"survival":[163,166,195],"overall":[165],"43":[168],"days":[169,172,178,181],"165":[171],"48":[177],"125":[180],"B.":[184],"Elevated":[185],"d-dimer":[186,218],"levels":[187,222],"thrombin-antithrombin":[189,220],"complexes":[190],"associated":[192,224],"decreased":[194,229],"increased":[197,226],"toxicity.":[198],"CONCLUSION:":[199],"Bevacizumab":[200],"without":[203],"does":[205],"not":[206],"have":[207],"activity":[209],"gemcitabine-refractory":[211],"Baseline":[215],"on-treatment":[217],"complex":[221],"toxicity":[227],"survival.":[230]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}